Literature DB >> 16045370

Medication adherence and diabetes control in urban African Americans with type 2 diabetes.

Felicia Hill-Briggs1, Tiffany L Gary, Lee R Bone, Martha N Hill, David M Levine, Frederick L Brancati.   

Abstract

In 181 urban African Americans with Type 2 diabetes, medication adherence was assessed using a measure designed specifically for an urban, impoverished sociodemographic population. Hemoglobin A-sub(1c), blood pressure and cholesterol levels, medication-related beliefs, and depression were assessed. Seventy-four percent of the sample reported adherence to diabetes medication. Adherence, adjusted for age, was associated with lower hemoglobin A-sub(1c). The specific behaviors associated with poorer diabetes control were forgetting to take medications and running out of medications. Knowledge of blood glucose goals differed for adherers and nonadherers. Blood pressure and cholesterol medication adherence rates were not associated with actual levels of blood pressure or lipids, respectively. These data suggest that specific medication-taking behaviors are important to diabetes control and constitute logical targets for interventions. ((c) 2005 APA, all rights reserved).

Entities:  

Mesh:

Year:  2005        PMID: 16045370     DOI: 10.1037/0278-6133.24.4.349

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  27 in total

1.  Obesity Modifies the Association of Race/Ethnicity with Medication Adherence in the CARDIA Study.

Authors:  Maribel Salas; Catarina I Kiefe; Pamela J Schreiner; Yongin Kim; Lucia Juarez; Sharina D Person; O Dale Williams
Journal:  Patient       Date:  2008-01-01       Impact factor: 3.883

Review 2.  What are validated self-report adherence scales really measuring?: a systematic review.

Authors:  Thi-My-Uyen Nguyen; Adam La Caze; Neil Cottrell
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

Review 3.  The association between the measurement of adherence to anti-diabetes medicine and the HbA1c.

Authors:  Sheila A Doggrell; Servane Warot
Journal:  Int J Clin Pharm       Date:  2014-03-22

4.  Perspectives of non-Hispanic Black and Latino patients in Boston's urban community health centers on their experiences with diabetes and hypertension.

Authors:  Beverley E Russell; Edith Gurrola; Chima D Ndumele; Bruce E Landon; James A O'Malley; Tom Keegan; John Z Ayanian; Leroi S Hicks
Journal:  J Gen Intern Med       Date:  2010-02-24       Impact factor: 5.128

5.  Individual-, Community-, and Health System-Level Barriers to Optimal Type 2 Diabetes Care for Inner-City African Americans: An Integrative Review and Model Development.

Authors:  Jennifer A Campbell; Leonard E Egede
Journal:  Diabetes Educ       Date:  2019-12-05       Impact factor: 2.140

6.  Control of medical comorbidities in individuals with HIV.

Authors:  Anne K Monroe; Geetanjali Chander; Richard D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2011-12-15       Impact factor: 3.731

7.  Appointment adherence and disparities in outcomes among patients with diabetes.

Authors:  Joel M Schectman; John B Schorling; John D Voss
Journal:  J Gen Intern Med       Date:  2008-07-26       Impact factor: 5.128

8.  A culturally targeted self-management program for African Americans with type 2 diabetes mellitus.

Authors:  Janice Collins-McNeil; Christopher L Edwards; Bryan C Batch; Debra Benbow; Camela S McDougald; Daphne Sharpe
Journal:  Can J Nurs Res       Date:  2012-12

9.  Medication adherence and racial differences in A1C control.

Authors:  Alyce S Adams; Connie Mah Trinacty; Fang Zhang; Ken Kleinman; Richard W Grant; James B Meigs; Stephen B Soumerai; Dennis Ross-Degnan
Journal:  Diabetes Care       Date:  2008-01-30       Impact factor: 19.112

10.  Diabetic patients' medication underuse, illness outcomes, and beliefs about antihyperglycemic and antihypertensive treatments.

Authors:  James E Aikens; John D Piette
Journal:  Diabetes Care       Date:  2008-10-13       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.